AHR Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

615.39M

+13.39%

0.158

-175%

627.87M

+16.14%

0.153

-483.33%

639.55M

+17.89%

0.203

+238.88%

Estimates Revision

The market is revising Upward the revenue expectations for American Healthcare REIT, Inc. (AHR) for FY2025, with the revenue forecasts being adjusted by 3.07% over the past three months. During the same period, the stock price has changed by 11.61%.

Revenue Estimates for FY2025

Revise Upward

+3.07%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+68.96%

In Past 3 Month

Stock Price

Go Up

+11.61%

In Past 3 Month

10 Analyst Rating

Wall Street analysts forecast AHR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AHR is 55.20 USD with a low forecast of 47.00 USD and a high forecast of 60.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

9 Buy

1 Hold

0 Sell

Strong Buy

Current: 47.200

Low

47.00

Averages

55.20

High

60.00

Current: 47.200

Low

47.00

Averages

55.20

High

60.00

Truist

Buy

upgrade

$46 -> $53

2025-11-26

Reason

Truist

Price Target

$46 -> $53

2025-11-26

upgrade

Buy

Reason

Truist raised the firm's price target on American Healthcare REIT to $53 from $46 and keeps a Buy rating on the shares. The firm is raising its FFO estimates and price target following strong results and higher earnings guidance, the analyst tells investors in a research note. American Healthcare REIT appears very well positioned to benefit from favorable industry trends, the firm added.

Citi

Neutral

maintain

$45 -> $52

2025-11-21

Reason

Citi

Price Target

$45 -> $52

2025-11-21

maintain

Neutral

Reason

Citi raised the firm's price target on American Healthcare REIT to $52 from $45 and keeps a Neutral rating on the shares. The firm updated the company's model post the Q3 report.

Morgan Stanley

Overweight

maintain

$52 -> $55

2025-11-20

Reason

Morgan Stanley

Price Target

$52 -> $55

2025-11-20

maintain

Overweight

Reason

Morgan Stanley raised the firm's price target on American Healthcare REIT (AHR) to $55 from $52 and keeps an Overweight rating on the shares. After examining Q3 results as well as supply/demand fundamentals in senior housing, the firm says it has higher conviction in Welltower (WELL) and American Healthcare's ability to execute on margin upside.

UBS

Buy

maintain

$51 -> $56

2025-11-17

Reason

UBS

Price Target

$51 -> $56

2025-11-17

maintain

Buy

Reason

UBS raised the firm's price target on American Healthcare REIT to $56 from $51 and keeps a Buy rating on the shares.

BofA

Buy

maintain

$51 -> $60

2025-11-17

Reason

BofA

Price Target

$51 -> $60

2025-11-17

maintain

Buy

Reason

BofA raised the firm's price target on American Healthcare REIT to $60 from $51 and keeps a Buy rating on the shares. While stock performance did not reflect it, Q3 earnings season was "strong" for U.S. REITs as 69% of REITs beat the Street, the analyst tells investors in a note on the group.

Morgan Stanley

Ronald Kamdem

Overweight

maintain

$48 -> $52

2025-11-17

Reason

Morgan Stanley

Ronald Kamdem

Price Target

$48 -> $52

2025-11-17

maintain

Overweight

Reason

Morgan Stanley analyst Ronald Kamdem raised the firm's price target on American Healthcare REIT to $52 from $48 and keeps an Overweight rating on the shares after update the firm's FY25 and FY26 FFO per share estimates to reflect Q3 earnings.

Valuation Metrics

The current forward P/E ratio for American Healthcare REIT Inc (AHR.N) is 65.24, compared to its 5-year average forward P/E of 473.81. For a more detailed relative valuation and DCF analysis to assess American Healthcare REIT Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

473.81

Current PE

65.24

Overvalued PE

1552.34

Undervalued PE

-604.72

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

17.52

Current EV/EBITDA

24.21

Overvalued EV/EBITDA

20.87

Undervalued EV/EBITDA

14.17

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

1.96

Current PS

3.35

Overvalued PS

2.80

Undervalued PS

1.12

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders areSelling! The selling amount has increased 562.32% over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders areSelling! The selling amount has increased 562.32% over the last month.

Sold

Bought

AHR News & Events

Events Timeline

No data

News

8.0

12-03NASDAQ.COM

American Healthcare REIT (AHR) Surpasses 2% Yield Threshold

4.0

11-22NASDAQ.COM

Citigroup Upholds Neutral Rating on American Healthcare REIT (AHR)

6.0

11-21Benzinga

Citigroup Keeps Neutral Rating on American Healthcare REIT and Increases Price Target to $52

People Also Watch

Frequently Asked Questions

What is American Healthcare REIT Inc (AHR) stock price today?

The current price of AHR is 47.2 USD — it has decreased -0.11 % in the last trading day.

What is American Healthcare REIT Inc (AHR)'s business?

American Healthcare REIT, Inc. is a real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate, focusing primarily on senior housing, skilled nursing facilities, outpatient medical (OM) buildings and other healthcare-related facilities across the United States, the United Kingdom and the Isle of Man. It owns and operates its integrated senior health campuses and senior housing operating properties (SHOP). Its segments include integrated senior health campuses, OM, SHOP and triple-net leased properties. Its OM buildings are leased to multiple tenants under separate leases. Its integrated senior health campuses each provide a range of independent living, assisted living, memory care, skilled nursing services and ancillary businesses. Its triple-net leased properties segment includes senior housing, skilled nursing facilities and hospitals. Its SHOP segment includes senior housing providing assisted living care, and others.

What is the price predicton of AHR Stock?

What is American Healthcare REIT Inc (AHR)'s revenue for the last quarter?

American Healthcare REIT Inc revenue for the last quarter amounts to 572.94M USD, increased 9.38 % YoY.

What is American Healthcare REIT Inc (AHR)'s earnings per share (EPS) for the last quarter?

American Healthcare REIT Inc. EPS for the last quarter amounts to 0.33 USD, decreased -1200.00 % YoY.

What changes have occurred in the market's expectations for American Healthcare REIT Inc (AHR)'s fundamentals?

How many employees does American Healthcare REIT Inc (AHR). have?

American Healthcare REIT Inc (AHR) has 114 emplpoyees as of December 16 2025.

What is American Healthcare REIT Inc (AHR) market cap?

Today AHR has the market capitalization of 8.41B USD.